Skip Navigation
Menu
Editorials |5 June 2018

Prescription Drug Monitoring Programs: Promising Practices in Need of Refinement

Wilson M. Compton, MD, MPE; Eric M. Wargo, PhD

Article, Author, and Disclosure Information
Author, Article, and Disclosure Information
This article was published at Annals.org on 8 May 2018.
  • National Institute on Drug Abuse, Bethesda, Maryland (W.M.C., E.M.W.)

    Disclaimer: The opinions expressed in this commentary are those of the authors and do not necessarily reflect the views of the National Institute on Drug Abuse, the National Institutes of Health, or the U.S. Department of Health and Human Services.

    Disclosures: Disclosures can be viewed at www.acponline.org/authors/icmje/ConflictOfInterestForms.do?msNum=M18-0883.

    Requests for Single Reprints: Wilson M. Compton, MD, MPE, 6001 Executive Boulevard, MSC 9581, Bethesda, MD 20892; e-mail, wcompton@nida.nih.gov.

    Current Author Addresses: Dr. Compton: 6001 Executive Boulevard, MSC 9581, Bethesda, MD 20892.

    Dr. Wargo: National Institute on Drug Abuse, 6001 Executive Boulevard, Bethesda, MD 20892.

×
FULL TEXT
Although recent data indicate that overdose deaths involving illicit opioids (including heroin and, especially, synthetic opioids, such as fentanyl and related compounds) have escalated in the past 3 years, widespread overprescription, diversion, and misuse of opioid analgesics started the crisis (1). Prescription opioids remain a major contributor to overdose deaths and serve as an entry point for many persons to become addicted to opioids, even if they switch to illicit opioids later because of lower cost and progression of their opioid use disorder (2–4).
Implementation of prescription drug monitoring programs (PDMPs) has been among the many policy-level efforts to curb irresponsible prescribing and diversion of opioids. The expectation is that providing clinicians with PDMP data on other medications their patients may be receiving will change their prescribing practices. In some jurisdictions, law enforcement may use these data to identify potentially illegal prescribing activity. However, although PDMPs now exist in all states and the District of Columbia, their implementation varies greatly. In addition, research assessing the effect of PDMPs on opioid misuse, diversion, and overdose has been sparse. Thus, the systematic review by Fink and colleagues (5) on the association between PDMPs and overdoses is a welcome contribution.
FULL TEXT
PDF
Not Available
Citations
Citation

Compton WM, Wargo EM. Prescription Drug Monitoring Programs: Promising Practices in Need of Refinement. Ann Intern Med. ;168:826–827. doi: 10.7326/M18-0883

Download citation file:

© 2019

×
Permissions

Published: Ann Intern Med. 2018;168(11):826-827.

DOI: 10.7326/M18-0883

Published at www.annals.org on 8 May 2018

0 Citations

Related Articles
Association Between Prescription Drug Monitoring Programs and Nonfatal and Fatal Drug Overdoses: A Systematic Review
Annals of Internal Medicine; 168 (11): 783-790
Medication for Opioid Use Disorder After Nonfatal Opioid Overdose and Association With Mortality: A Cohort Study
Annals of Internal Medicine; 169 (3): 137-145
Overdose Prevention Through Medical Treatment of Opioid Use Disorders
Annals of Internal Medicine; 169 (3): 190-192
Every Cloud Has a Silver Lining: Overdose-Death Donors in Organ Transplantation
Annals of Internal Medicine; 168 (10): 739-740
View MoreView Less

Journal Club
Use of long-acting, vs short-acting, opioids for chronic pain was linked to unintentional overdose
Annals of Internal Medicine; 163 (2): JC11
View MoreView Less

Related Topics
Emergency Medicine
Tobacco, Alcohol, and Other Substance Abuse

Emergency Medicine, Tobacco, Alcohol, and Other Substance Abuse.

PubMed Articles
Enhanced Intranasal Absorption of Naltrexone by Dodecyl Maltopyranoside: Implications for the Treatment of Opioid Overdose.
J Clin Pharmacol 2019.
Propagation of pericentral necrosis during acetaminophen-induced liver injury: evidence for early interhepatocyte communication and information-exchange.
Toxicol Sci 2019.
View More

Results provided by: PubMed

CONTINUE WITH LIMITED ACCESS
Annals of Internal Medicine
To receive access to the full text of freely available articles, alerts, and more. You will be directed to acponline.org to complete your registration.
×
acp link acp
silverchair link silverchair

Copyright © 2019 American College of Physicians. All Rights Reserved.

Print ISSN: 0003-4819 | Online ISSN: 1539-3704

Privacy Policy

|

Conditions of Use

This site uses cookies. By continuing to use our website, you are agreeing to our privacy policy. | Accept
×

You need a subscription to this content to use this feature.

×
PDF Downloads Require Access to the Full Article.
Annals of Internal Medicine
To receive access to the full text of freely available articles, alerts, and more. You will be directed to acponline.org to complete your registration.
×
Access to this Free Content Requires Users to be Registered and Logged In. Please Choose One of the Following Options
Annals of Internal Medicine
To receive access to the full text of freely available articles, alerts, and more. You will be directed to acponline.org to complete your registration.
×